Organization Profile

Related Organization(s)

You just read:

Akcea and Ionis Announce Positive Results from Pivotal Study of Volanesorsen in Patients with Familial Chylomicronemia Syndrome (FCS)

News provided by

Ionis Pharmaceuticals, Inc.

Mar 06, 2017, 14:30 ET